CME Group Inc (NASDAQ:CME) saw some unusual options trading on Thursday. Investors bought 16,399 call options on the stock. This represents an increase of approximately 764% compared to the typical daily volume of 1,899 call options.
In related news, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction dated Thursday, October 11th. The stock was sold at an average price of $179.86, for a total transaction of $449,650.00. Following the sale, the chief financial officer now owns 32,720 shares in the company, valued at approximately $5,885,019.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $172.30, for a total value of $51,690.00. Following the sale, the director now owns 42,912 shares in the company, valued at approximately $7,393,737.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 29,800 shares of company stock worth $5,628,462. 0.43% of the stock is owned by corporate insiders.
Several institutional investors have recently modified their holdings of CME. BlackRock Inc. grew its holdings in shares of CME Group by 1.8% in the third quarter. BlackRock Inc. now owns 22,422,112 shares of the financial services provider’s stock valued at $3,816,468,000 after acquiring an additional 403,327 shares in the last quarter. Capital International Investors grew its holdings in shares of CME Group by 18.3% in the third quarter. Capital International Investors now owns 15,425,378 shares of the financial services provider’s stock valued at $2,625,554,000 after acquiring an additional 2,383,280 shares in the last quarter. Capital Research Global Investors grew its holdings in shares of CME Group by 107.8% in the third quarter. Capital Research Global Investors now owns 10,906,683 shares of the financial services provider’s stock valued at $1,856,427,000 after acquiring an additional 5,658,108 shares in the last quarter. Edgewood Management LLC grew its holdings in shares of CME Group by 9.5% in the third quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock valued at $1,460,830,000 after acquiring an additional 742,067 shares in the last quarter. Finally, Janus Henderson Group PLC grew its holdings in shares of CME Group by 3.3% in the third quarter. Janus Henderson Group PLC now owns 6,331,522 shares of the financial services provider’s stock valued at $1,077,689,000 after acquiring an additional 202,365 shares in the last quarter. 85.89% of the stock is owned by hedge funds and other institutional investors.
Shares of CME Group stock opened at $187.11 on Friday. The company has a market capitalization of $63.96 billion, a PE ratio of 39.23, a P/E/G ratio of 2.19 and a beta of 0.46. CME Group has a 52 week low of $143.68 and a 52 week high of $197.08. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, topping the consensus estimate of $1.42 by $0.03. The firm had revenue of $904.20 million during the quarter, compared to the consensus estimate of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. On average, equities research analysts predict that CME Group will post 6.65 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be paid a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.
A number of research firms recently weighed in on CME. Barclays began coverage on CME Group in a research note on Tuesday. They set an “overweight” rating and a $210.00 price target on the stock. Zacks Investment Research downgraded CME Group from a “buy” rating to a “hold” rating in a research note on Friday. Atlantic Securities began coverage on CME Group in a research note on Wednesday, November 28th. They set a “neutral” rating and a $200.00 price target on the stock. Berenberg Bank raised CME Group from a “hold” rating to a “buy” rating and set a $220.00 price target on the stock in a research note on Tuesday, November 20th. Finally, BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, October 9th. Six investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $194.13.
COPYRIGHT VIOLATION WARNING: This article was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/12/08/investors-buy-large-volume-of-cme-group-call-options-cme.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Further Reading: Buyback For Investors Defined
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.